121 related articles for article (PubMed ID: 35380497)
1. Comparison of MRI Features of Fat Fraction and ADC for Early Treatment Response Assessment in Participants with Multiple Myeloma.
Koutoulidis V; Terpos E; Papanikolaou N; Fontara S; Seimenis I; Gavriatopoulou M; Ntanasis-Stathopoulos I; Bourgioti C; Santinha J; Moreira JM; Kastritis E; Dimopoulos MA; Moulopoulos LA
Radiology; 2022 Jul; 304(1):137-144. PubMed ID: 35380497
[TBL] [Abstract][Full Text] [Related]
2. Treatment Response Assessment in Multiple Myeloma: Histogram Analysis of Total Tumor Apparent Diffusion Coefficient based on Whole-body Diffusion-weighted MR Imaging.
Gao Y; Wang Q; Zhang L; Li S; Liu D; Wang S; Zhu J; Zhang H; Xie S; Xia S; Huang W; Xue H; Li J
J Magn Reson Imaging; 2023 Dec; ():. PubMed ID: 38088500
[TBL] [Abstract][Full Text] [Related]
3. Assessment of early treatment response on MRI in multiple myeloma: Comparative study of whole-body diffusion-weighted and lumbar spinal MRI.
Takasu M; Kondo S; Akiyama Y; Takahashi Y; Maeda S; Baba Y; Kawase T; Ichinohe T; Awai K
PLoS One; 2020; 15(2):e0229607. PubMed ID: 32106239
[TBL] [Abstract][Full Text] [Related]
4. Histogram Analysis Based on Apparent Diffusion Coefficient Maps of Bone Marrow in Multiple Myeloma: An Independent Predictor for High-risk Patients Classified by the Revised International Staging System.
Wang Q; Zhang L; Li S; Sun Z; Wu X; Zhao A; Benkert T; Zhou D; Xue H; Jin Z; Li J
Acad Radiol; 2022 Jun; 29(6):e98-e107. PubMed ID: 34452820
[TBL] [Abstract][Full Text] [Related]
5. Deep Learning for Automatic Bone Marrow Apparent Diffusion Coefficient Measurements From Whole-Body Magnetic Resonance Imaging in Patients With Multiple Myeloma: A Retrospective Multicenter Study.
Wennmann M; Neher P; Stanczyk N; Kahl KC; Kächele J; Weru V; Hielscher T; Grözinger M; Chmelik J; Zhang KS; Bauer F; Nonnenmacher T; Debic M; Sauer S; Rotkopf LT; Jauch A; Schlamp K; Mai EK; Weinhold N; Afat S; Horger M; Goldschmidt H; Schlemmer HP; Weber TF; Delorme S; Kurz FT; Maier-Hein K
Invest Radiol; 2023 Apr; 58(4):273-282. PubMed ID: 36256790
[TBL] [Abstract][Full Text] [Related]
6. Discriminating Depth of Response to Therapy in Multiple Myeloma Using Whole-body Diffusion-weighted MRI with Apparent Diffusion Coefficient: Preliminary Results From a Single-center Study.
Wu C; Huang J; Xu WB; Guan YJ; Ling HW; Mi JQ; Yan H
Acad Radiol; 2018 Jul; 25(7):904-914. PubMed ID: 29373210
[TBL] [Abstract][Full Text] [Related]
7. Baseline bone marrow ADC value of diffusion-weighted MRI: a potential independent predictor for progression and death in patients with newly diagnosed multiple myeloma.
Zhang L; Wang Q; Wu X; Zhao A; Feng J; Zhang H; Cao X; Li S; Cai H; Sun Z; Duan M; Zhu T; Zhang W; Jin Z; Zhou D; Xue H; Li J
Eur Radiol; 2021 Apr; 31(4):1843-1852. PubMed ID: 32965573
[TBL] [Abstract][Full Text] [Related]
8. More accurate prediction of treatment response than mean apparent diffusion coefficient value in multiple myeloma using whole body MRI histogram analysis.
Qi Q; Dong H; Ji X; Zhang K; Zou D; Hao M; Deng S; Sui W; Song Z; Yu Z; Shen Z; Huang W; Xia S
Future Oncol; 2023 Jun; 19(17):1175-1185. PubMed ID: 37386939
[No Abstract] [Full Text] [Related]
9. Prediction of Early Treatment Response in Multiple Myeloma Using MY-RADS Total Burden Score, ADC, and Fat Fraction From Whole-Body MRI: Impact of Anemia on Predictive Performance.
Dong H; Huang W; Ji X; Huang L; Zou D; Hao M; Deng S; Shen Z; Lu X; Wang J; Song Z; Zhang X; Xue H; Xia S
AJR Am J Roentgenol; 2022 Feb; 218(2):310-319. PubMed ID: 34523949
[No Abstract] [Full Text] [Related]
10. Mean Apparent Diffusion Coefficient Is a Sufficient Conventional Diffusion-weighted MRI Metric to Improve Breast MRI Diagnostic Performance: Results from the ECOG-ACRIN Cancer Research Group A6702 Diffusion Imaging Trial.
McDonald ES; Romanoff J; Rahbar H; Kitsch AE; Harvey SM; Whisenant JG; Yankeelov TE; Moy L; DeMartini WB; Dogan BE; Yang WT; Wang LC; Joe BN; Wilmes LJ; Hylton NM; Oh KY; Tudorica LA; Neal CH; Malyarenko DI; Comstock CE; Schnall MD; Chenevert TL; Partridge SC
Radiology; 2021 Jan; 298(1):60-70. PubMed ID: 33201788
[TBL] [Abstract][Full Text] [Related]
11. Diffusion-weighted MRI in Advanced Epithelial Ovarian Cancer: Apparent Diffusion Coefficient as a Response Marker.
Winfield JM; Wakefield JC; Dolling D; Hall M; Freeman S; Brenton JD; Lutchman-Singh K; Pace E; Priest AN; Quest RA; Taylor NJ; Gabra H; McKnight L; Collins DJ; Banerjee S; Hall E; deSouza NM
Radiology; 2019 Nov; 293(2):374-383. PubMed ID: 31573402
[TBL] [Abstract][Full Text] [Related]
12. Quantitative bone marrow magnetic resonance imaging through apparent diffusion coefficient and fat fraction in multiple myeloma patients.
Berardo S; Sukhovei L; Andorno S; Carriero A; Stecco A
Radiol Med; 2021 Mar; 126(3):445-452. PubMed ID: 32812173
[TBL] [Abstract][Full Text] [Related]
13. Differentiation of Diffuse Infiltration Pattern in Multiple Myeloma From Hyperplastic Hematopoietic Bone Marrow: Qualitative and Quantitative Analysis Using Whole-Body MRI.
Sun M; Cheng J; Ren C; Zhang Y; Li Y; Wang L; Liu Y
J Magn Reson Imaging; 2022 Apr; 55(4):1213-1225. PubMed ID: 34558141
[TBL] [Abstract][Full Text] [Related]
14. Whole body magnetic resonance imaging in newly diagnosed multiple myeloma: early changes in lesional signal fat fraction predict disease response.
Latifoltojar A; Hall-Craggs M; Rabin N; Popat R; Bainbridge A; Dikaios N; Sokolska M; Rismani A; D'Sa S; Punwani S; Yong K
Br J Haematol; 2017 Jan; 176(2):222-233. PubMed ID: 27766627
[TBL] [Abstract][Full Text] [Related]
15. Comparison of qualitative and quantitative CT and MRI parameters for monitoring of longitudinal spine involvement in patients with multiple myeloma.
Horger M; Fritz J; Thaiss WM; Ditt H; Weisel K; Haap M; Kloth C
Skeletal Radiol; 2018 Mar; 47(3):351-361. PubMed ID: 29222688
[TBL] [Abstract][Full Text] [Related]
16. Apparent diffusion coefficient maps integrated in whole-body MRI examination for the evaluation of tumor response to chemotherapy in patients with multiple myeloma.
Bonaffini PA; Ippolito D; Casiraghi A; Besostri V; Franzesi CT; Sironi S
Acad Radiol; 2015 Sep; 22(9):1163-71. PubMed ID: 26182979
[TBL] [Abstract][Full Text] [Related]
17. Extended Texture Analysis of Non-Enhanced Whole-Body MRI Image Data for Response Assessment in Multiple Myeloma Patients Undergoing Systemic Therapy.
Ekert K; Hinterleitner C; Baumgartner K; Fritz J; Horger M
Cancers (Basel); 2020 Mar; 12(3):. PubMed ID: 32213834
[TBL] [Abstract][Full Text] [Related]
18. Differentiation of multiple myeloma and metastases: Use of axial diffusion-weighted MR imaging in addition to standard MR imaging at 3T.
Park GE; Jee WH; Lee SY; Sung JK; Jung JY; Grimm R; Son Y; Paek MY; Min CK; Ha KY
PLoS One; 2018; 13(12):e0208860. PubMed ID: 30557373
[TBL] [Abstract][Full Text] [Related]
19. Whole-body MRI quantitative biomarkers are associated significantly with treatment response in patients with newly diagnosed symptomatic multiple myeloma following bortezomib induction.
Latifoltojar A; Hall-Craggs M; Bainbridge A; Rabin N; Popat R; Rismani A; D'Sa S; Dikaios N; Sokolska M; Antonelli M; Ourselin S; Yong K; Taylor SA; Halligan S; Punwani S
Eur Radiol; 2017 Dec; 27(12):5325-5336. PubMed ID: 28656463
[TBL] [Abstract][Full Text] [Related]
20. Locally advanced rectal cancer: post-chemoradiotherapy ADC histogram analysis for predicting a complete response.
Cho SH; Kim GC; Jang YJ; Ryeom H; Kim HJ; Shin KM; Park JS; Choi GS; Kim SH
Acta Radiol; 2015 Sep; 56(9):1042-50. PubMed ID: 25270374
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
